Cancer


How long does someone live with Acute Myeloid Leukemia? Doctors explain life expectancy and what factors can affect your circumstances.
Get exclusive access to our latest content as soon as it's filmed for free at https://www.healthtree.org/aml/university
HealthTree University for acute myeloid leukemia offers a comprehensive online curriculum with lessons, quizzes and course discussion. Create a free account today to track your progress, earn points to win prizes, and stay up to date on the latest advancements in treating AML!
Topics covered include: AML basics, allogeneic stem cell transplant, AML genetics, relapsed and refractory AML and much more. We've partnered with AML experts to help you learn quickly. Improve the way you navigate your disease and obtain better outcomes with HealthTree University.
Stay up to date on the latest AML news through our newsletter! https://healthtree.org/aml/community/newsletter
Follow HealthTree:
Twitter: https://www.twitter.com/HealthTreeAML
Facebook: https://www.facebook.com/HealthTreeForAML
Instagram: https://www.instagram.com/healthtreeforaml


Learn more about AML at http://www.YouAndAML.com
In this video, expert Dr. David Steensma explains that there are a number of types of acute myeloid leukemia (AML). Types include treatment-related AML, also called secondary or therapy-related AML (tAML), AML with myelodysplasia-related changes (AML-MRC), and acute promyelocytic leukemia (APL). The different types of AML can make it a challenge to match the treatment to each patient.


#shorts
“Envision” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 4.0 License
http://creativecommons.org/licenses/by/4.0/
Get exclusive access to our latest content as soon as it's filmed for free at https://www.healthtree.org/aml/university
HealthTree University for acute myeloid leukemia offers a comprehensive online curriculum with lessons, quizzes and course discussion. Create a free account today to track your progress, earn points to win prizes, and stay up to date on the latest advancements in treating AML!
Topics covered include: AML basics, allogeneic stem cell transplant, AML genetics, relapsed and refractory AML and much more. We've partnered with AML experts to help you learn quickly. Improve the way you navigate your disease and obtain better outcomes with HealthTree University.
Stay up to date on the latest AML news through our newsletter! https://healthtree.org/aml/community/newsletter
We'd like to thank our faculty who donated their time in creating these videos, including:
• Joseph Jurcic, MD | Columbia University
Follow HealthTree:
Twitter: https://www.twitter.com/HealthTreeAML
Facebook: https://www.facebook.com/HealthTreeForAML
Instagram: https://www.instagram.com/healthtreeforaml


Learn more about AML at http://www.YouAndAML.com
This animation provides an overview of treatment failure and relapse in acute myeloid leukemia (AML). Treatment failure occurs when your AML treatment is not successful in eliminating all the leukemia from your bone marrow after initial therapy (induction chemotherapy). It could also mean that the leukemia came back (relapsed) after being well controlled after chemotherapy and entering a state known as remission. You can learn about how often AML relapse occurs, who is at risk, why complete remission is less common in older adults, as well as cytogenetics and AML treatment failure.


Learn more about AML at http://www.YouAndAML.com
Dr. Sandra Kurtin, an expert on acute myeloid leukemia (AML), describes some of the symptoms of AML in this video. Symptoms can come on suddenly and include fever, shortness of breath, weakness, weakness, dizziness, and headaches. You may feel like you have the flu. You might also bruise or bleed easily. Some people have milder symptoms that appear over time, such as being very tired. Changes in the various types of blood cells produce different symptoms.


To continue this series: https://wb.md/2MYi1zW
A team of New York doctors is changing the course of acute myeloid leukemia by finding and killing cancer cells before the disease can clinically recur, extending remission -- and survival.